Evidence map›Paper›PMID 31933897›Full record

ArticleInternational journal of clinical and experimental pathology2019

The role of autophagy and Beclin-1 in radiotherapy-induced apoptosis in thyroid carcinoma cells.

Peng Gao, Fengjin Hao, Xiu Dong, Yan Qiu

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Peng GaoNuclear Medicine Department, Cancer Hospital of China Medical University No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, P. R. China.
Fengjin HaoDepartment of Biochemistry and Molecular Biology, China Medical University Shenyang 110122, Liaoning, P. R. China.
Xiu DongSchool of Preclinical Medicine, Liaoning University of Traditional Chinese Medicine 79 Chong Shan Dong Lu, Huanggu District, Shenyang 110847, Liaoning, P. R. China.
Yan QiuNuclear Medicine Department, Cancer Hospital of China Medical University No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, P. R. China.
Liaoning Cancer Hospital & Institute · CNChina Medical University · CNLiaoning University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesThyroid cancer (TC), especially primary squamous cell carcinoma (SCC), is an aggressive malignant tumor which usually resists radiotherapy (RT). We wanted to understand the mechanism of incomplete response of RT in TC cells.

methodsSCC cell line SW579 cells were exposed to X-rays. Apoptosis and autophagy were measured by FACS; 3MA, inhibitor of autophagy, and Beclin-1 siRNA were used to investigate the effect of autophagy on radiation-induced TC cell apoptosis.

resultsRT could induce TC cell apoptosis through death receptor as well as mitochondrial pathway. Radiotherapy also induces autophagy and increases expression of autophagy-associated proteins Beclin-1 and LC3. Moreover, inhibition of autophagy by 3MA and Beclin-1 siRNA enhanced radiation-induced apoptosis, through up-regulation of the expression of p53.

conclusionRT-induced autophagy resists apoptosis by the p53 pathway and an incomplete response to RT may be associated with autophagy in TC patients.

Indexed as

apoptosisAutophagyBeclin-1radiotherapythyroid carcinoma cells

Identifiers

PMID31933897
PMCPMC6945190
OpenAlexW3007228391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.